Medeze Group

Medeze Group Interest Coverage

The Interest Coverage Ratio of Medeze Group (MEDEZE.BK) as of Oct 27, 2026 is 81.42. In the previous year, Interest Coverage Ratio was 31.80 — a change of 156.01% (higher).

Interest Coverage

81.42

YoY

156.01%

Last updated:

Interest Coverage Ratio of Medeze Group is 2024 81.42 . Interest Coverage Ratio of Medeze Group was 2023 31.80 . It decreases by 156.01% higher compared to the previous year.

The Medeze Group Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
5.54 THB
Jan 1, 2018
12.75 THB
Jan 1, 2019
0.54 THB
Jan 1, 2020
3.13 THB
Jan 1, 2021
26.67 THB
Jan 1, 2022
15.12 THB
Jan 1, 2023
31.80 THB
Jan 1, 2024
81.42 THB
The Medeze Group Interest Coverage history
YEARInterest CoverageYoY
81.42+156.01%
31.80+110.27%
15.12-43.30%
26.67+752.46%
3.13+476.92%
0.54-95.75%
12.75+130.22%
5.54—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medeze Group Stock analysis

What does Medeze Group do? Medeze Group PLC operates as a mesenchymal stem cell bank in Thailand, offering stem cell storage services from umbilical cord tissue and adipose tissue, alongside umbilical cord blood storage. The company provides stem cell analysis, separation, cultivation, and storage services, including immune cell potential testing for Natural killer cells. Its white blood cell potential testing service segment evaluates NK cell performance and count, while the other services segment delivers research, data collection on human cellular activities, and medical laboratory tests. The sales of products segment generates revenue through dietary supplements, cosmetics, and dermo cosmetics. The company's primary customers are individuals seeking stem cell storage for future medical use, as well as those requiring immune cell testing and research services. The stem cell sample collection service segment targets expectant parents and medical institutions for cord blood and tissue storage. The white blood cell potential testing service segment serves healthcare providers and patients interested in NK cell analysis. The sales of products segment appeals to consumers purchasing dietary supplements and cosmetic products. Medeze Group PLC's revenue streams are derived from multiple segments: stem cell storage services, immune cell testing, research and laboratory services, and product sales. The stem cell sample collection and storage services form the core offering, while the white blood cell potential testing and other services provide additional value. Product sales contribute to revenue through the distribution of dietary supplements, cosmetics, and dermo cosmetics, targeting both individual consumers and healthcare-focused markets. Medeze Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medeze Group stock

Interest Coverage Ratio of Medeze Group is 81.42 in 2024.

Interest Coverage Ratio of Medeze Group changed from 31.80 to 81.42, representing a 156.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Medeze Group since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Medeze Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medeze Group

All Key Metrics — Medeze Group